10261511000001103: Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)
\UK product\Virtual medicinal product\Product containing precisely hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet\Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)
\UK product\Virtual therapeutic moiety\Olmesartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and olmesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet\Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)
\UK product\Virtual therapeutic moiety\Olmesartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet\Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)
\UK product\Trade family\Olmetec Plus\Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

35447901000001115 Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

39727601000001112 Olmetec Plus 20mg/12.5mg tablets (Daiichi Sankyo UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Is a	Product containing precisely hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Has active ingredient	Hydrochlorothiazide	false	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Has active ingredient	Olmesartan medoxomil	false	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Is a	Olmetec Plus	true	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Has specific active ingredient	Olmesartan medoxomil	true	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Has specific active ingredient	Hydrochlorothiazide	true	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet	Is pack of	False	Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Inferred relationship	Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet	Has AMP	True	Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
35447901000001115	Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
39727601000001112	Olmetec Plus 20mg/12.5mg tablets (Daiichi Sankyo UK Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module